Sp1128
CLINICAL CHARACTERISTICS OF PAIN IN PATIENTS WITH ACTIVE IBD AND DURING REMISSION
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
AGA Gut-Brain Communication
Gathering evidence suggests that communication between the gut and brain plays a major role in health and disease. However, our understanding of the mechanisms underlying gut-brain communication is a major unresolved field of neurogastroenterology…
INTRODUCTION
SOCIETY: AGA
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…